Literature DB >> 25939292

New cholesterol guidelines for the management of atherosclerotic cardiovascular disease risk: a comparison of the 2013 American College of Cardiology/American Heart Association cholesterol guidelines with the 2014 National Lipid Association recommendations for patient-centered management of dyslipidemia.

Bhavin B Adhyaru1, Terry A Jacobson2.   

Abstract

This review discusses the 2013 American College of Cardiology (ACC)/American Heart Association (AHA) Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults and compares it with the 2014 National Lipid Association (NLA) Recommendations for Patient-Centered Management of Dyslipidemia. The review discusses some of the distinctions between the guidelines, including how to determine a patient's atherosclerotic cardiovascular disease risk, the role of lipoprotein treatment targets, the importance of moderate- and high-intensity statin therapy, and the use of nonstatin therapy in light of the IMProved Reduction of Outcomes: Vytorin Efficacy International Trial (IMPROVE-IT) trial.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Atherogenic cholesterol; Atherosclerotic cardiovascular disease (ASCVD); Clinical recommendations; Dyslipidemia; Guidelines; Low-density lipoprotein cholesterol (LDL-C)

Mesh：

Substances：

Year:  2015        PMID： 25939292     DOI： 10.1016/j.ccl.2015.02.001

Source DB:  PubMed          Journal:  Cardiol Clin        ISSN： 0733-8651            Impact factor:   2.213


  11 in total

Review 1.  Novel Biomarker Approaches for Managing Patients With Cardiac Transplantation.

Authors:  Peter J Kennel; P Christian Schulze
Journal:  Curr Heart Fail Rep       Date:  2015-10

Review 2.  Role of Non-Statins, LDL-C Thresholds, and Special Population Considerations: A Look at the Updated 2016 ACC Consensus Committee Recommendations.

Authors:  Bhavin B Adhyaru; Terry A Jacobson
Journal:  Curr Atheroscler Rep       Date:  2017-06       Impact factor: 5.113

3.  Association Between Long-Term Lipid Profiles and Disease Severity in a Large Cohort of Patients with Inflammatory Bowel Disease.

Authors:  Efstratios Koutroumpakis; Claudia Ramos-Rivers; Miguel Regueiro; Jana G Hashash; Arthur Barrie; Jason Swoger; Leonard Baidoo; Marc Schwartz; Michael A Dunn; Ioannis E Koutroubakis; David G Binion
Journal:  Dig Dis Sci       Date:  2015-10-29       Impact factor: 3.199

4.  Innovative Approaches to Teaching Dyslipidemia Management in a Required Pharmacy Therapeutics Sequence.

Authors:  Laura H Waite; Alice L Scaletta; Diane E Hadley
Journal:  Am J Pharm Educ       Date:  2018-09       Impact factor: 2.047

5.  Evaluation of Statin Eligibility, Prescribing Practices, and Therapeutic Responses Using ATP III, ACC/AHA, and NLA Dyslipidemia Treatment Guidelines in a Large Urban Cohort of HIV-Infected Outpatients.

Authors:  Matthew E Levy; Alan E Greenberg; Manya Magnus; Naji Younes; Amanda Castel
Journal:  AIDS Patient Care STDS       Date:  2018-02       Impact factor: 5.078

6.  Improvement in lipids after switch to boosted atazanavir or darunavir in children/adolescents with perinatally acquired HIV on older protease inhibitors: results from the Pediatric HIV/AIDS Cohort Study.

Authors:  J Jao; W Yu; K Patel; T L Miller; B Karalius; M E Geffner; L A DiMeglio; A Mirza; J S Chen; M Silio; E J McFarland; R B Van Dyke; D Jacobson
Journal:  HIV Med       Date:  2017-11-21       Impact factor: 3.180

7.  Society for Vascular Nursing endovascular repair of abdominal aortic aneurysm updated nursing clinical practice guideline.

Authors:  Debra Kohlman-Trigoboff; Kathleen Rich; Anne Foley; Karen Fitzgerald; Dianne Arizmendi; Carolyn Robinson; Rebecca Brown; Diane Treat-Jacobson
Journal:  J Vasc Nurs       Date:  2020-05-21

8.  Serum CETP and PLTP activity in middle-aged men living in urban or rural area of the Lower Silesia region. PURE Poland sub-study.

Authors:  Anna Skoczyńska; Anna Wojakowska; Barbara Turczyn; Katarzyna Zatońska; Maria Wołyniec; Andrzej Szuba
Journal:  Arch Med Sci       Date:  2016-07-01       Impact factor: 3.318

9.  Effects of 12-week supplementation of Citrus bergamia extracts-based formulation CitriCholess on cholesterol and body weight in older adults with dyslipidemia: a randomized, double-blind, placebo-controlled trial.

Authors:  Yong Cai; Guoqiang Xing; Tian Shen; Shuxian Zhang; Jianyu Rao; Rong Shi
Journal:  Lipids Health Dis       Date:  2017-12-22       Impact factor: 3.876

10.  Bergamot Reduces Plasma Lipids, Atherogenic Small Dense LDL, and Subclinical Atherosclerosis in Subjects with Moderate Hypercholesterolemia: A 6 Months Prospective Study.

Authors:  Peter P Toth; Angelo M Patti; Dragana Nikolic; Rosaria V Giglio; Giuseppa Castellino; Teresa Biancucci; Fabiana Geraci; Sabrina David; Giuseppe Montalto; Ali Rizvi; Manfredi Rizzo
Journal:  Front Pharmacol       Date:  2016-01-06       Impact factor: 5.810
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.